Slicing through the challenge of maintaining Pneumocystis in the laboratory

Olga A Nev1,2, Lucian Duvenage2,3,4, Alistair J P Brown2

  • 1Biosciences and Living Systems Institute, University of Exeter, Exeter, United Kingdom.

Mbio
|February 12, 2024
PubMed

Insights

Researchers developed a new method to study Pneumocystis, a fungus causing lung infections. This advance allows for longer observation of the pathogen in lung tissue, aiding in understanding its behavior and developing treatments.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Pneumocystis jirovecii is a significant human fungal pathogen responsible for severe pneumonia in immunocompromised individuals.
  • Limited understanding of Pneumocystis pathobiology is due to the inability to culture it independently of a host.
  • This hinders research into virulence factors and effective antifungal therapies.

Purpose of the Study:

  • To establish a novel in vitro model for studying Pneumocystis.
  • To enable long-term observation of Pneumocystis in a host-mimicking environment.
  • To facilitate the investigation of fungal virulence and drug responses.

Main Methods:

  • Utilized precision-cut lung slices (PCLSs) from mice to culture Pneumocystis murina.
  • Maintained both trophozoite and cyst stages of the fungus in PCLSs for extended periods.
  • Employed PCLSs as a platform for studying fungal-host interactions.

Main Results:

  • Successfully maintained Pneumocystis murina in PCLSs for several weeks.
  • Demonstrated the viability of both trophozoite and cyst forms in this model.
  • Showcased the potential of PCLSs for investigating fungal biofilm formation and antifungal drug efficacy.

Conclusions:

  • Precision-cut lung slices provide a viable ex vivo model for studying Pneumocystis.
  • This model system offers new avenues for exploring Pneumocystis virulence mechanisms, including biofilm formation.
  • The PCLS model is a promising tool for evaluating antifungal drug responses in a relevant lung environment.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
219
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
327
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
238